Annual Meeting Abstract Submissions

These words define abstract as existing in thought, or as an idea, not having a physical or concrete existence.

USCAP defines abstract as the synoptic summary of your intellectual focus or research investigation. Convert your thought or idea into something concrete.

Abstract submissions will open Wednesday, August 18, 2021. The submission deadline will be

Tuesday, September 28 at 3:00 PM Eastern Daylight Time/12:00 PM Pacific Daylight Time.

Requirements

Scientific material must be original and not previously published, nor currently accepted for publication or presentation at another meeting prior to the USCAP 2022 Annual Meeting.

USCAP Embargo Policy

Unless otherwise noted, all abstracts presented at the USCAP Annual Meeting are embargoed until the date and time of presentation. They cannot be presented in any national or international forum or be published (online of print) in abstract or manuscript form prior to first day of the USCAP annual meeting. USCAP reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during the USCAP Annual Meeting.

Category Descriptions

Autopsy and Forensics: This category includes abstracts describing pathology related to adult autopsy. It excludes abstracts describing pediatric autopsy, fetal pathology, and autopsy-related neuropathology.

Bone and Soft Tissue Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of soft tissues and bone. It does not include abstracts describing cutaneous soft tissue tumors or mesenchymal tumors of the gastrointestinal tract.

Breast Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the breast. Abstracts describing mesenchymal tumors and hematopoietic disorders of the breast are included.

Cardiovascular Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the heart and blood vessels. Cardiac transplantation pathology is included.

Cytopathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of all sites encountered in exfoliative or fine needle aspiration samples.

Dermatopathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the skin. Abstracts describing cutaneous mesenchymal and hematopoietic tumors are included.

Education: This category includes abstracts describing innovation and application of existing platforms (e.g. social media) to pathology education. Topics may be related to specific organ systems or general anatomic pathology.

Endocrine Pathology: This category includes abstracts describing diseases of the thyroid gland, parathyroid glands, adrenal glands, and paraganglia. It does not include abstracts describing disorders of the pancreas, endocrine tumors of the gastrointestinal tract, or pituitary diseases.

Gastrointestinal Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the tubular gastrointestinal tract. Abstracts describing mesenchymal tumors (e.g. gastrointestinal stromal tumor), hematopoietic tumors, and bowel transplantation pathology are included. This category excludes abstracts describing diseases of the gallbladder, pancreas, liver, ampulla, and extrahepatic biliary tree.

General Surgical Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases that are not limited to one organ system (e.g. molecular analysis of squamous cell carcinomas from different sites, or novel immunohistochemical markers that have diagnostic applications to multiple sites).

Genitourinary Pathology: This category includes abstracts describing neoplastic diseases of the kidneys, as well as both neoplastic and non-neoplastic disorders of the ureters, urinary bladder, prostate, penis, and testis. This category does not include abstracts describing medical renal disease or transplantation pathology.

Gynecologic Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the ovaries, fallopian tubes, uterus, cervix, vagina, and vulva. It also includes abstracts describing placental and obstetric pathology. It does not include abstracts describing primary peritoneal neoplasms.

Head and Neck Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the oral cavity, nasopharynx, paranasal sinuses, larynx, and salivary glands. It does not include abstracts describing cutaneous diseases of the face or disorders of the thyroid and parathyroid glands.

Hematopathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of lymph nodes, bone marrow elements, spleen, and dendritic cells. It does not include thymoma or thymic carcinoma. Abstracts describing disorders involving specific sites (e.g. skin, gastrointestinal tract, central nervous system) may be more appropriately submitted to other categories.

Infectious Disease Pathology: This category includes abstracts describing non-neoplastic diseases of an infectious etiology that affect multiple organs or organ systems. Abstracts describing disorders confined to one organ or organ system (e.g. pulmonary fungal infections) and those discussing pathogen-driven neoplasia may be more appropriately submitted to other categories.

Informatics: This category includes abstracts describing issues related to pathology information systems, digital pathology, data analysis, information technology, machine learning, and similar topics. Abstracts describing application of these techniques to pathology education or diseases of one organ and/or one organ system may be more appropriately submitted to other categories.

Liver Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the liver. Liver transplantation pathology and tumors and inflammatory conditions of the intrahepatic bile ducts are included. Disorders of the extrahepatic bile ducts and gallbladder are excluded.

Medical Renal Pathology: This category includes abstracts describing issues related to non-neoplastic renal diseases as well as transplantation pathology. It does not include abstracts describing neoplastic diseases of the kidney.

Neuropathology and Ophthalmic Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the central nervous system and its coverings, pituitary gland, and eye. Autopsy neuropathology is included. Abstracts describing myopathies and peripheral neuropathies are included.

Pancreas, Gallbladder, Ampulla and Extra-hepatic Bile Ducts: This category includes abstracts describing neoplastic and non-neoplastic diseases of the pancreas, gallbladder, ampulla, and extra-hepatic bile ducts up to the hilum. Endocrine/neuroendocrine tumors of the pancreas and pancreatic transplantation pathology are included.

Pathobiology and Emerging Techniques: This category includes abstracts that emphasize disease biology or describe issues related to oncogenesis and pathogenesis of non-neoplastic conditions and highlight new assays and platforms that may have diagnostic or prognostic value in the pathologic assessment of human diseases. Pan-genomic/pan-proteomic approaches and ultrastructural pathology are generally included, although abstracts describing application of these techniques to diseases of one organ or one organ system may be more appropriately submitted to other categories.

Pediatric and Perinatal Pathology: This category includes abstracts describing neoplastic and non-neoplastic diseases of the pediatric population, perinatal diseases, and fetal autopsies.

Pulmonary, Mediastinum, Pleura, and Peritoneum: This category includes abstracts describing neoplastic and non-neoplastic diseases of the tracheobronchial tree, lungs, pleura, and mesothelial surfaces of the peritoneal cavity. It also includes thymoma, thymic carcinoma, and mediastinal germ cell tumors. It does not include lymphomas.

Quality and Patient Safety: This category includes abstracts describing the study of risk to patients in pathology as well as failure to meet standards of timeliness, report accuracy, and transfer of materials between services. It includes abstracts describing baseline data collection followed by an intervention and analysis of post-implementation data.

Abstracts may be moved from the category of submission to another category by the Abstract Assignment Committee as appropriate.

USCAP Embargo Policy

Unless otherwise noted, all abstracts accepted for presentation at the USCAP Annual Meeting are embargoed from submission until the date and time of presentation. They cannot be presented in any national or international forum or be published (online or print) in abstract or manuscript form prior to the first day of the USCAP annual meeting. USCAP reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during the USCAP Annual Meeting.

If the accepted abstract is also submitted as a manuscript for publication, authors are responsible for coordinating a publication date that abides by the Academy’s embargo policy. If publication occurs online or in print before the USCAP 2022 Annual Meeting, March 19-24, 2021, the abstract must be withdrawn. Please notify the Academy via e-mail at support@uscap.org.